One of today's notable stocks on the rise is Amgen (NASDAQ:AMGN), up 2.0% to $104.40. The S&P is trading higher by 0.7% to 1,573 and the Dow is trading 0.7% higher to 14,671.
In the past 52 weeks, shares of Amgen have traded between a low of $65.37 and a high of $104.43 and are now at $104.40, which is 60% above that low price. The 200-day and 50-day moving averages have moved 0.40% higher and 0.80% higher over the past week, respectively.
Based on a current price of $104.40, Amgen is currently 6.5% above its average consensus analyst price target of $97.62. Amgen shares have support at the 50-day moving average (MA) of $89.37 and additional support at the 200-day MA of $84.76.
Amgen Inc. discovers, develops, manufactures, and markets human therapeutics based on cellular and molecular biology. The Company focuses its research on secreted protein and small molecule therapeutics, with particular emphasis on neuroscience and cancer. Amgen concentrates on the areas of hematology, cancer, infectious disease, endocrinology, neurobiology, and inflammation.